The efficacy of cognitive remediation on processing speed in patients with first episode psychosis
- Conditions
- PsychosisMental and Behavioural DisordersUnspecified nonorganic psychosis
- Registration Number
- ISRCTN17220814
- Lead Sponsor
- Public Service Department of Malaysia
- Brief Summary
2019 Results article in https://doi.org/10.35940/ijitee.L1110.10812S219 results (added 09/12/2020) 2019 Results article in http://sersc.org/journals/index.php/IJAST/article/view/2443 results (added 09/12/2020)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 92
1. First-episode psychosis patients with schizophrenia, schizophreniform disorder or schizoaffective disorder at diagnosis and presenting with cognitive deficits
2. Young adults aged 18 to 40
3. Able to read and write in Malay and/or English
4. Written informed consent
5. Fulfil the criteria of cognitive measures, symptomatology and other functioning
6. The symptoms must have been present during the past year including other criteria
1. Previous diagnosis of mental retardation, psychotic disorder related to a general medical condition or substance-induced psychotic disorder
2. Severe schizophrenia
3. History of any diagnosis of a serious developmental disorder
4. Significant ongoing neurological disorders including epilepsy
5. History of severe head injury
6. Concurrently undergoing other types of cognitive remediation therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cognitive functioning, assessed by neurocognitive assessment through The Brief Assessment of Cognition in Schizophrenia (BACS) at baseline and 8 weeks
- Secondary Outcome Measures
Name Time Method Functional outcomes, assessed using functional measures including Schizophrenia Cognition Rating Scale (SCoRS), Social Functioning Scale (SFS), Social and Occupational Functioning Assessment Scale (SOFAS) and Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4) at baseline and 8 weeks